All lobbying filings
Curaleaf Inc.
Curaleaf Inc. filed a Q2 report for Curaleaf Inc. on July 14, 2026.
Lobbying for Curaleaf Inc.
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 14, 2026
Expenses
$80,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Massachusetts
Government bodies contacted
2
Lobbying activity
4
Proposals to create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and services for such businesses (SAFE Banking Act).The Capital Lending and Investment for Marijuana Businesses Act (CLIMB Act).
The removal of Schedule III (Controlled Substances Act) limitations for cannabis.
Tax issues relating to cannabis.
Inclusion of cannabis employees in job reports.